You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Efficient Lossless EEG Compression Engine

    SBC: Alacron, Inc.            Topic: N/A

    We will develop an advanced lossless data compression engine for EEG, for use in telephone EEG transystems and digital EEG recording systems. While useful in rural and remote setting without ready acelectroencephalographers, and for home monitoring in selected patients with epilepsy and sleep distuavailable EEG telephone transmission systems restrict the number of channels of EEG transmitted andof ...

    SBIR Phase I 1995 Department of Health and Human Services
  2. 26-Hydroxycholesterol--Therapy for Ctx and Restenosis

    SBC: ALBANY MOLECULAR RESEARCH, INC.            Topic: N/A

    26-Hydroxycholesterol is a naturally occurring metabolic product derived from cholesterol. Recent isuggest that this metabolite plays a role as a feedback inhibitor of cholesterol synthesis and may bregulation of LDL receptors. The absence of 26-hydroxycholesterol has been postulated to be the molegenetic disease cerebrotendinous xanthomatosis. The discovery that this compound is produced in vascs ...

    SBIR Phase I 1995 Department of Health and Human Services
  3. DISCOVERY OF CDK INHIBITORS AS ANTITUMOR AGENTS

    SBC: ALBANY MOLECULAR RESEARCH, INC.            Topic: N/A

    The discovery of inhibitors of cyclin/cyclin dependent kinase (cdk) complexes is proposed which may have an antiprolifertive/antitumor effect of cells. Because overexpression of various cyclins have differential oncogenic potential, inhibitors will be assayed against a panel of cyclin/cdks. The goal of Phase I is to discover a compound which inhibits one or more cyclin/cdk complexes with a 10-fo ...

    SBIR Phase I 1997 Department of Health and Human Services
  4. PORTABLE MULTIMEDIA FOR FAMILY CAREGIVER TRAINING

    SBC: American Research Corporation of Virginia            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  5. ALKYLTRANSFERASE IN METASTATIC MALIGNANT MELANOMA

    SBC: Applied Genetics, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  6. IDENTIFICATION OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGENS

    SBC: Argonex, Inc.            Topic: N/A

    In the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach aimed at the identification of these antigens, termed Direct Identification of Relevant Epitopes for ...

    SBIR Phase I 1997 Department of Health and Human Services
  7. TACTILE GRAPHIC PRINTER PROJECT (TGPP)

    SBC: Automated Functions, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  8. ALGORITHM FOR 3D IMAGING OF THE EYE'S POSTERIOR POLE

    SBC: LICKENBROCK TECHNOLOGIES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  9. DEVELOPMENT OF GENETICALLY HYPERTENSIVE DOGS

    SBC: Butler Farms Usa, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  10. SCREEN--REGULATOR OF HEMATOPOIETIC CELL RESTRICTED PTP1C

    SBC: Cadus Pharmaceutical            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
US Flag An Official Website of the United States Government